Impact Biomedical Inc. (NYSEAMERICAN:IBO – Get Free Report) was the recipient of a significant drop in short interest in the month of September. As of September 30th, there was short interest totaling 30,169 shares, a drop of 94.3% from the September 15th total of 526,986 shares. Approximately 3.2% of the company’s shares are short sold. Based on an average daily volume of 15,208 shares, the days-to-cover ratio is currently 2.0 days.
Impact Biomedical Stock Performance
Impact Biomedical stock traded up $0.14 during trading hours on Friday, reaching $4.25. 4,014 shares of the company’s stock traded hands, compared to its average volume of 14,890. Impact Biomedical has a fifty-two week low of $4.06 and a fifty-two week high of $10.47. The firm’s 50 day moving average is $5.79 and its 200-day moving average is $6.60.
Impact Biomedical (NYSEAMERICAN:IBO – Get Free Report) last posted its quarterly earnings results on Friday, August 7th. The company reported ($0.13) earnings per share for the quarter. Impact Biomedical had a return on equity of 8.81% and a net margin of 2,254.28%. The business had revenue of $0.00 million for the quarter.
About Impact Biomedical
Impact Biomedical, Inc is a biotechnology and life sciences company focused on developing and commercializing biomedical technologies, pharmaceutical products and related health solutions. Its activities have included research into antiviral, antimicrobial and anti-inflammatory applications, with an emphasis on technologies intended to address infectious diseases and other public health needs.
The company has described a portfolio of biomedical intellectual property and development programs rather than a broad portfolio of established commercial products.
See Also
- Five stocks we like better than Impact Biomedical
- 3 Unique ETFs With Strong Momentum for the End of the Year
- 3 Beaten-Down Biotech Stocks With Triple-Digit Upside and Big Catalysts Ahead
- Schneider Just Paid Up for PTC—Is the SaaSpocalypse Overdone?
- Delta Air Lines Faces a Fuel Crisis—But There’s a Silver Lining
Receive News & Ratings for Impact Biomedical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Impact Biomedical and related companies with MarketBeat.com's FREE daily email newsletter.
